If you know us, you know that Science excites us! :) Today, we have a particularly beautiful reason to celebrate. Just look at the image of the eye captured by our technology — we are truly mesmerized by the clarity it brings to the naked eye. In a serendipitous moment on the eve of World AIDS Day, Remidio’s widefield imaging technology was granted a patent! Our technology, in partnership with Seva Foundation, is being deployed to screen for CMV retinitis. This infection compromises the vision of those with weakened immune systems, including individuals living with HIV/AIDS, potentially leading to irreversible vision loss and shortened lifespans. Yet, there is hope as early detection and treatment can change outcomes. We are excited to explore this technology holds towards enhancing the identification of peripheral retinal conditions due to its larger field of view. We also hold the patent for this technology for the US, European, and Japanese market. Congratulations to our R&D team on this remarkable achievement! Patting ourselves on the back here. #remidio #teamremidio #researchanddevelopment #innovation #eyecare #worldaidsday
The Vistaro has made it easier for infectionists to screen for CMV retinitis and other retinal conditions in an age where NCD’s are on the rise. Integrated care for PLWHIV just got a boost with this.
Congratulations, Remidio team! 🎉 This is truly a good achievement, and your dedication to advancing medical technology is inspiring. The impact on identifying and treating peripheral retinal conditions is invaluable. Keep pushing the boundaries of innovation! 👏 #remidio #innovation #eyecare #congrats
Congratulations
Enjoy making your applications upon my foundation.
11moCongratulations It is indeed great news for the whole world that medical science is empowered by the technology in service of humanity. Thanks to the Remidio.